DOI: 10.1093/bjs/znad258.646 ISSN:

1221 Recipient Outcomes After Simultaneous Pancreas and Kidney Transplant Delineated by Donor eGFR

R Owen, N Fitzpatrick, C Counter, A Malik, B Mahendran, S Tingle, C Wilson, D Manas, N Sheerin, S White
  • Surgery



This study aimed to assess if the use of kidneys with a decreased eGFR had an adverse effect on patient and graft survival.


Data on all UK SPKT’s from 2001-2021 were obtained from the NHSBT UK Transplant Registry (n = 2,631). Cases with missing information were removed, leaving a final cohort of 1,819 (69.1%). eGFR was calculated using the CKD-EPI equation. Pancreas Graft (PGS), Kidney Graft (KGS) and patient survival analyses were conducted using Kaplan-Meier plots and Cox-regression models.


71% (n = 1,292) of grafts were from donors with an eGFR>90 and 29%(n = 530) were from donors with an eGFR<90. Donors with an eGFR<90 were statistically significantly more likely to be older (p<0.0001), a DBD donor (p = 0.0086**) and have a higher BMI(p<0.0001). Recipients who received a graft from a donor with an eGFR<90 were well matched with those who received a graft from a donor with an eGFR>90. Univariate analysis showed a statistically significant decreased KGS(p = 0.007**) when the donor had an eGFR<90. This trend was not seen when comparing patient or pancreas survival.


We accept a lower GFR could be indicative of either an AKI or a sign of early chronic kidney disease. In this current data analysis, we have been unable to successfully distinguish between the two however we have shown poorer KGS in those with a lower eGFR (<90). This had no impact on pancreas or patient survival. Further analysis is needed to explain the precise reasons for the lower eGFR’s at the time of organ donation.

More from our Archive